Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

June 16, 2025

Share This

Jared Holz, Mizuho, joins ‘Fast Money’ to talk the fallout for Sarepta after another death related to its muscular dystrophy gene therapy.

Latest Mizuho News

Mizuho Financial Group launches strategic technology and operations center in Pune

Mizuho Financial Group launches strategic technology and operations center in Pune

May 21, 2026

A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

May 19, 2026

Why biotechnology stocks have more room to run

Why biotechnology stocks have more room to run

May 12, 2026

Mizuho news from around the globe

Mizuho Global News